Abstract Details

Title The Symbol Digit Modalities Test (SDMT) Has Been the Standard Cognitive Measure Used in Multiple Sclerosis (MS) Clinical Trials: How Does It Correlate with Computerized Cognitive Screening Tools?

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 169

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Mark Gudesblatt, MD (South Shore Neurology Assoc. PC) PRESENTER	No disclosure on file
Myassar Zarif	No disclosure on file
Barbara Bumstead, NP	No disclosure on file
Marijean Buhse (Stony Brook University)	No disclosure on file
	No disclosure on file
Cynthia L. Sullivan, PhD (Neuropsychology Associates of Fairfax)	No disclosure on file
	No disclosure on file
Jeffrey A. Wilken, PhD (NAF)	No disclosure on file
Glen M. Doniger, PhD (NeuroTrax Israel Ltd.)	No disclosure on file
	No disclosure on file